D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Astronics
ATRO
$3.39B
| $577K | ﹤0.01% |
+21,175
| New | +$564K |
|
|
HAPN
2877
Happen Inc
HAPN
$2.14B
| $575K | ﹤0.01% |
37,219
+19,358
| +108% | +$299K |
|
2878
US Physical Therapy
USPH
$1.15B
| $575K | ﹤0.01% |
+5,471
| New | +$588K |
|
2879
America's Car Mart
CRMT
$29M
| $571K | ﹤0.01% |
6,249
+76
| +1% | +$5.91K |
|
|
ARQL
2880
DELISTED
Arqule Inc
ARQL
| $569K | ﹤0.01% |
118,701
-189,355
| -61% | -$731K |
|
2881
Fresenius Medical Care
FMS
$13.4B
| $568K | ﹤0.01% |
14,010
-197,754
| -93% | -$7.37M |
|
|
STKL
2882
DELISTED
SunOpta
STKL
| $568K | ﹤0.01% |
164,057
-47,214
| -22% | -$183K |
|
2883
Vanda Pharmaceuticals
VNDA
$318M
| $568K | ﹤0.01% |
+30,845
| New | +$703K |
|
|
ZAYO
2884
PUT
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $568K | ﹤0.01% |
+20,000
| New | +$530K |
|
2885
PUT
Crane NXT
CXT
$3.06B
| $567K | ﹤0.01% |
+19,289
| New | +$546K |
|
2886
Towne Bank
TOWN
$3.44B
| $566K | ﹤0.01% |
22,875
-3,579
| -14% | -$94K |
|
2887
Xenon Pharmaceuticals
XENE
$6.29B
| $565K | ﹤0.01% |
55,632
-75,588
| -58% | -$641K |
|
2888
CALL
Advance Auto Parts
AAP
$3.48B
| $563K | ﹤0.01% |
3,300
-14,500
| -81% | -$2.34M |
|
2889
PUT
Matador Resources
MTDR
$6.08B
| $563K | ﹤0.01% |
+29,100
| New | +$542K |
|
2890
CALL
Constellation Brands
STZ
$22.2B
| $561K | ﹤0.01% |
3,200
-161,100
| -98% | -$27.1M |
|
|
VIAB
2891
PUT
DELISTED
Viacom Inc. Class B
VIAB
| $561K | ﹤0.01% |
20,000
-61,500
| -75% | -$1.77M |
|
2892
Park Aerospace
PKE
$768M
| $558K | ﹤0.01% |
35,558
+25,008
| +237% | +$471K |
|
2893
PUT
Warner Bros
WBD
$64B
| $557K | ﹤0.01% |
20,600
-19,400
| -49% | -$540K |
|
|
CALY
2894
Callaway Golf Company
CALY
$3.26B
| $555K | ﹤0.01% |
34,871
-44,636
| -56% | -$734K |
|
2895
Renasant Corp
RNST
$4.04B
| $554K | ﹤0.01% |
16,377
-21,065
| -56% | -$751K |
|
2896
PUT
Applied Industrial Technologies
AIT
$12.8B
| $553K | ﹤0.01% |
+9,300
| New | +$539K |
|
2897
Houlihan Lokey
HLI
$9.75B
| $553K | ﹤0.01% |
12,065
-25,654
| -68% | -$1.13M |
|
|
LNW
2898
CALL
DELISTED
Light & Wonder
LNW
| $553K | ﹤0.01% |
27,100
-2,900
| -10% | -$69.3K |
|
2899
Children's Place
PLCE
$52.7M
| $553K | ﹤0.01% |
5,689
-10,911
| -66% | -$995K |
|
2900
RLI Corp
RLI
$5.87B
| $553K | ﹤0.01% |
15,418
-18,066
| -54% | -$623K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.